The US Food and Drug Administration has approved adalimumab-adaz (Hyrimoz), a biosimilar to adalimumab (Humira), for the treatment of rheumatoid arthritis, juvenile...
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
New results from the COMPASS trial showed further cardiovascular benefits of rivaroxaban, when combined with aspirin. Find out the new indications here.
In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...